Although it is not a new disease, an appetite disorder can be related to modern lifestyle. In an attempt to reduce the weight and bring the body into shape people tend to decrease the normal food consumption. It is largely explained as a disturbed eating habit or disorders leading to significant impairing of physical and psychological health of the patient. Eating disorder also occurs with variety of other psychiatric illnesses such as substance abuse, anxiety disorder, depression and other similar conditions. In addition, people suffering from appetite disorders can experience a wide range of physical health complications such as serious heart conditions and kidney failure among others which may lead to even death.
Appetite disorder market: Categories
Two of the prominent categories of the eating disorders include anorexia nervosa and bulimia nervosa. In anorexia nervosa, people tend to starve themselves for extreme weight loss whereas in bulimia nervosa a person tend to vomit after having food more than a stipulated amount every time. Females are more prone to eating or appetite disorders as compared to men. According to an article published in Psychology Today, approximately 0.5% to 3.7% of the female population suffers from anorexia nervosa whereas, an estimated 1.1% to 4.2% of the female population have bulimia nervosa in their lifetime. In the United States approximately 7 million women and 1 million men suffer from appetite disorder
Obtain Report Details @
Appetite disorder market: Major drivers
Major drivers to appetite disorder include genetics, abnormal level of biochemical in the body, psychological and environmental factors. With respect to genetics, identical twins are more likely to have higher rate of eating disorder as compared to fraternal twins or other siblings. Stress is another prominent cause of eating disorders. Many research studies have found that patients suffering from bulimia and anorexia have considerably higher level of stress hormones such as cortisol and serotonin. Environmental factors such as family and relationship problems, sexual abuse, disturbed childhood and peer problem can also significantly contribute towards appetite disorders. Despite of all these findings till date, the exact cause of the eating disorders is still unknown.
Appetite disorder market: Available drugs
Available treatment for appetite disorder includes nutritional therapy and drug therapy. Some of the commonly used drugs include antidepressants, antipsychotics, calcium plus vitamin D supplement and gastrointestinal stimulants among others. Lack of awareness about the disorder and absence of professional help in developing economic countries are some of the key restraints to the uptake of appetite disorder market. Cultural, professional and social compulsions such as requirements in the entertainment industry, modeling and a blurred perception of what a healthy body should look like has been a major cause of anorexia and bulimia. Several not-for-profit organizations have been creating awareness of the problems caused by social perceptions and demands in society for having a thin body particularly in females. This was conventionally upheld as a parameter for visual appeal, but is now slowly changing, with reducing number of cases over the world.
Appetite disorder market: Affected regions
Geographically, developed economic countries such as the United States and Europe are more prone to appetite disorder as compared to developing economic region primarily due to unhealthy eating habits and lifestyle related disorders. Intense research and development and awareness among people regarding eating disorder in developed economic countries are another contributing factor for increase in revenues in these two geographic regions. Many companies such as GlaxoSmithKline plc, Medisyn Technologies, Inc., Omeros Corporation are conducting rigorous clinical trial activities to develop novel drugs for patient suffering from appetite disorders. Asia-Pacific and Rest of the World are one of the fastest growing region owing to increase in disposable income, increasing influence and impact of camouflaging western culture lifestyle and rising incidences of obesity related disorders among mid-aged people.
Some of the prominent companies operating in Appetite (Eating) Disorders Market include GlaxoSmithKline plc, INSYS Therapeutics, Inc., Global Health Ventures Inc., Omeros Corporation, Kuhnil Pharmaceutical Co., Ltd., Medisyn Technologies, Inc., Lightlake Therapeutics Inc. among other players.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Fill the form for an exclusive sample of this report @
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.